Targeting Phosphodiesterases in Anti-Platelet Therapy

Handbook of Experimental Pharmacology - Germany
doi 10.1007/978-3-642-29423-5_9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Berlin Heidelberg

Related search

Kawasaki Disease – Options for Anti-Platelet Therapy

Austin Journal of Pharmacology and Therapeutics
2017English

Anti-Platelet Therapy: Cyclo-Oxygenase Inhibition and the Use of Aspirin With Particular Regard to Dual Anti-Platelet Therapy

British Journal of Clinical Pharmacology
Pharmacology
2011English

Targeting PVR (CD155) and Its Receptors in Anti-Tumor Therapy

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2018English

Life-Saving Therapy Versus Symptom Relief: Anti-Platelet Agents and Opioids in Coronary Intervention

Thrombosis and Haemostasis
Hematology
2018English

Recent Anti-Platelet Therapy Revealing Underlying Undiagnosed Gastrointestinal Stromal Tumor in Otherwise Healthy Patient

Cureus
2020English

Combination of Cyclic Nucleotide Modulators With P2Y12 Receptor Antagonists as Anti-Platelet Therapy

Journal of Thrombosis and Haemostasis
MedicineHematology
2020English

Pharmacogenomics of Anti-Platelet Therapy: How Much Evidence Is Enough for Clinical Implementation?

Journal of Human Genetics
Genetics
2013English

Cannabis Joint Triggered Recurrent Anterior Myocardial Infarction in an Adolescent Taking Dual Anti-Platelet Therapy

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2012English

Differential Regulation of Human Platelet Responses by cGMP Inhibited and Stimulated cAMP Phosphodiesterases

Thrombosis and Haemostasis
Hematology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy